Its overexpression promoted the occurrence and development of colon cancer by competitively binding with miR-340-5p to regulate CLDN8/IL22 co-expression and activating ERK signaling pathway (Zhou et al., 2019). Here, IL22 is linked to malignant colon neoplasm.